Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 4
203
Views
4
CrossRef citations to date
0
Altmetric
Brief Report

Cytotoxic and anti-tumor effects of 3,4-seco-lupane triterpenoids from the leaves of Eleutherococcus sessiliflorus against hepatocellular carcinoma

, , , ORCID Icon, , , & show all
Pages 1062-1066 | Received 23 Jul 2020, Accepted 25 Oct 2020, Published online: 13 Nov 2020

References

  • Bian X, Zhao Y, Guo X, Zhang L, Li P, Fu T, Wang W, Yin Y, Chen G, Liu J. 2017. Chiisanoside, a triterpenoid saponin, exhibits anti-tumor activity by promoting apoptosis and inhibiting angiogenesis. RSC Adv. 7(66):41640–41650.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
  • Chen C, Zhang D, Zhao Y, Cai E, Zhu H, Gao Y. 2020. A new 3,4-seco-lupane triterpenene glycosyl ester from the leaves of Eleutherococcus sessiliflorus. Nat Prod Res. 34(13):1927–1930.
  • Forner A, Llovet JM, Bruix J. 2012. Hepatocellular carcinoma. Lancet. 379(9822):1245–1255.
  • Ma B, Zhang H, Wang Y, Zhao A, Zhu Z, Bao X, Sun Y, Li L, Zhang Q. 2018. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3. J Exp Clin Cancer Res. 37(1):210.
  • Song Y, Yang C-J, Wang Z-B, Zhao N, Feng X-S, Meng F-H. 2017. Chemical constituents of Eleutherococcus sessiliflorus extract and its sedative-hypnotic effect. Nat Prod Res. 31(17):1995–2000.
  • Zhang D, Chen C, Zhao Y, Gao Y, Cai E, Zhu H. 2019. 3,4-seco-lupane triterpene derivatives with cytotoxic activities from the leaves of Eleutherococcus sessiliflorus. Nat Prod Res. 1–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.